MCK

#148
McKesson Corporation
863.4800 USD
+0.06%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
863.4800
863.4800
Faixa anual
789.9600
999.0000
Mudança diária
+0.06%
Mudança mensal
-8.44%
Mudança em 6 meses
+7.60%
Mudança anual
+7.60%
Fechamento anterior
862.9550
Abrir
863.4800
Bid
Ask
Mínimo
863.4800
High
863.4800
Volume
1
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 105.7655 B
  • Employee 51 K
  • Founded N/A
  • CEO Brian S. Tyler
  • Website www.mckesson.com
  • Headquarter Delaware, United States
  • FIGI BBG000DYGNW7
  • Industry Distribuição médica
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
23.67
Índice preço/fluxo de caixa
0.26
Dividendos por ação
0.82
Rendimento de dividendos, %
0.62

McKesson Corporation

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

Notícias